BUFFALO, N.Y. — This afternoon, experts at Roswell Park Comprehensive Cancer Center discussed a new FDA approved therapy for lymphoma.
The new treatment known as Polivy can be used in combination with chemotherapy for patients with certain aggressive forms of lymphoma.
Roswell played an important role in developing the therapy for approval by the FDA.
This is the first time an immunotherapy from Roswell Park was included in an FDA approved treatment.